Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

Published:2007-01 Issue:6 Volume:46 Page:723-734
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Van Essen Martijn,Krenning Eric P.,De Jong Marion,Valkema Roelf,Kwekkeboom Dik J.

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860701441848

Reference70 articles.

1. Gastroenteropancreatic Endocrine Tumours: Effect of Sandostatin® on Tumour Growth

2. Long-Term Management of the Carcinoid Syndrome Treatment with octreotide alone and in combination with alpha-interferon

3. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors

4. Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

5. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents;Nature Reviews Endocrinology;2024-08-15

2. Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas;Frontiers in Endocrinology;2023-12-21

3. Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study;European Journal of Endocrinology;2023-11

4. Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas;Cancers;2023-09-21

5. Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists;Pharmaceuticals;2023-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3